The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

An Ayurvedic herb is causing a lot of excitement for it’s brain-boosting powers. Here’s what the evidence shows.

It affects sodium channels in the peripheral nervous system, that send pain signals to the brain. The drug eases pain by blocking these signals before they reach the brain. Pain is an unpleasant ...

The Food and Drug Administration ... on the brain. Vertex said the wholesale cost would be $15.50 per 50-milligram pill, or $31 for a recommended starting dose. “Today’s approval is an ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

The US medicines regulator approved ... brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids' addictive effects. Vertex’s drug ...

FDA Approves First New Non-Opioid Pain Pill in Decades By India Edwards HealthDay ... Unlike opioids, which bind to brain receptors to reduce pain but often lead to dependence and addiction ...

The US medicines regulator approved a new ... to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids' addictive ...